Tata Sons to foray into smartphone manufacturing: Sources-March 2024-www.financetom.com

Tata Sons to foray into smartphone manufacturing: Sources

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Tata Sons to foray into smartphone manufacturing: Sources

Dec 4, 2020 1:16 AM

Tata Sons is exploring various new businesses and one of them is smartphone manufacturing, sources said.

CNBC-TV18’s Nisha Poddar details out the kind of money the group is looking at for smartphone manufacturing.

Watch video for more details.

(Edited by : Ankit Gohel)

Previous page： Kyndryl Launches Autonomous AI Services to Speed Mainframe, Hybrid IT Development Next page： Keurig Dr Pepper Launches Coffee Product Line

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Kyndryl Launches Autonomous AI Services to Speed Mainframe, Hybrid IT Development

Nov 24, 2025

10:18 AM EST, 11/24/2025 (MT Newswires) -- Kyndryl Holdings ( KD ) introduced new autonomous artificial intelligence-powered services designed to build on its mainframe expertise and hybrid IT capabilities. The services are aimed at accelerating application development, improving operational agility, and expanding the use of AI for International Business Machines' ( IBM ) z/OS customers, Kyndryl ( KD ) said...

Keurig Dr Pepper Launches Coffee Product Line

Nov 24, 2025

10:19 AM EST, 11/24/2025 (MT Newswires) -- Keurig Dr Pepper ( KDP ) said Monday that it has launched Keurig Coffee Collective, its in-house coffee product line. The company said its coffee pods come in five flavor blends, currently available exclusively on the Keurig website and will expand to national retail in early 2026. Price: 27.33, Change: -0.41, Percent Change:...

LivaNova's VNS Therapy Gets Increased Provider Reimbursement Under US Medicare

Nov 24, 2025

10:20 AM EST, 11/24/2025 (MT Newswires) -- LivaNova ( LIVN ) said Monday that the provider reimbursement for its neuromodulation treatment, VNS Therapy, under Medicare will increase significantly, effective Jan. 1, 2026. The US Centers for Medicare & Medicaid Services assigned VNS Therapy to New Technology Ambulatory Payment Classification 1580 for new patient implants under the 2026 Medicare Hospital Outpatient...

Form 8.3

Nov 24, 2025

LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Charles Schwab Investment Management, Inc. (CSIM) in its capacity as investment advisor to clients. CSIM expressly disclaims beneficial ownership of the shares...